Letters to the EditorAnti-inflammatory effects of ivabradine in patients with acute coronary syndrome: a pilot study
Section snippets
Acknowledgements
The authors wish to express their gratitude to nurse Carmen Alexia Dorta Jimenez.
The authors of this manuscript have certified that the investigation complies with the Principles of Ethical Publishing in the International Journal of Cardiology (Shewan and Coats 2010;144:1–2).
References (14)
- et al.
The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen
Int J Cardiol
(2006) - et al.
C-reactive protein in acute coronary syndromes: a perfect trigger or an excellent indicator?
Int J Cardiol
(2008) - et al.
C-reactive protein and endothelial dysfunction: gazing at the coronaries
Int J Cardiol
(2011) Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein
Int J Cardiol
(2005)- et al.
C-reactive protein and endothelial dysfunction: the clinicians should have in mind diurnal variations
Int J Cardiol
(2012) - et al.
Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice
Atherosclerosis
(2010) - et al.
Vascular pathophysiology in response to increased heart rate
J Am Coll Cardiol
(2010)
There are more references available in the full text version of this article.
Cited by (0)
- 1
These authors contributed equally to the manuscript.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.